Labeler
Novartis Pharmaceuticals Corporation NDC Codes
Novartis Pharmaceuticals Corporation lists 165 finished drug products in the FDA NDC Directory under NDC labeler code 0078.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Entresto, Promacta, Jadenu, Exforge HCT, Vijoice, Cosentyx, Afinitor, Zortress, Tafinlar, Mekinist, Scemblix, Piqray, Mayzent, Kisqali, Sandostatin LAR Depot
- Active ingredients
- Valsartan, Everolimus, Sacubitril, Eltrombopag olamine, Deferasirox, Amlodipine besylate, Alpelisib, Hydrochlorothiazide, Secukinumab, Dabrafenib mesylate, Trametinib dimethyl sulfoxide, Asciminib hydrochloride
- NDC labeler codes
- 0078
- Strengths (from the 100 most recently listed products)
- Valsartan 160 mg/1; Amlodipine besylate 10 mg/1; Ribociclib succinate 200 mg/1; Hydrochlorothiazide 25 mg/1; Alpelisib 50 mg/1; Eltrombopag olamine 25 mg/1; Eltrombopag olamine 12.5 mg/1; Deferasirox 180 mg/1; Deferasirox 360 mg/1; Deferasirox 90 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Imatinib mesylate 400 mg/1; Everolimus 5 mg/1; Amlodipine besylate 5 mg/1; Hydrochlorothiazide 12.5 mg/1; Remibrutinib 25 mg/1; Atrasentan hydrochloride .75 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Kit, Injection, Solution, Injection, Granule, Tablet, For suspension, Injection, Suspension, Patch, Extended release, Pellet, Injection, Powder, Lyophilized, For solution, Powder, For suspension, Injection, Solution, Concentrate, Powder, For solution, Capsule, Liquid filled, Solution/ drops, Suspension/ drops
- Routes
- Oral, Intravenous, Subcutaneous, Ophthalmic, Transdermal, Intravitreal
- Drug classes (FDA established)
- Kinase Inhibitor, Angiotensin 2 Receptor Blocker, mTOR Inhibitor Immunosuppressant, Neprilysin Inhibitor, Thrombopoietin Receptor Agonist, Iron Chelator, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Sphingosine 1-phosphate Receptor Modulator, Thiazide Diuretic, Interleukin-17A Antagonist, Cholinesterase Inhibitor, CD19-directed Chimeric Antigen Receptor, Genetically-modified Autologous T Cells, Antimalarial, Endothelin Receptor Antagonist, Corticosteroid, Complement Factor B Inhibitor, Radioligand Therapeutic Agent, Selectin Blocker, Anthelmintic, Topoisomerase Inhibitor, Nucleoside Metabolic Inhibitor, Lymphocyte Function-Associated Antigen-1 Antagonist, Nonsteroidal Anti-inflammatory Drug, CD20-directed Cytolytic Antibody
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Rhapsidoremibrutinib | Remibrutinib 25 mg/1 | TabletOral | 0078-1483 | 00078-1483-2000078-1483-9200078-1483-93 | — |
| Vanrafiaatrasentan | Atrasentan hydrochloride .75 mg/1 | Tablet, Film coatedOral | 0078-1420 | 00078-1420-15 | — |
| Triesencetriamcinolone acetonide | Triamcinolone acetonide 40 mg/mL | Injection, SuspensionOphthalmic | 0078-0897 | 00078-0897-78 | — |
| Vijoicealpelisib | Alpelisib 50 mg/1 | GranuleOral | 0078-1175 | 00078-1175-51 | — |
| Entrestosacubitril and valsartan | Sacubitril 6 mg/1; Valsartan 6 mg/1 | PelletOral | 0078-1231 | 00078-1231-20 | — |
| Entrestosacubitril and valsartan | Sacubitril 15 mg/1; Valsartan 16 mg/1 | PelletOral | 0078-1238 | 00078-1238-20 | — |
| Fabhaltaiptacopan | Iptacopan hydrochloride 200 mg/1 | CapsuleOral | 0078-1189 | 00078-1189-20 | — |
| Cosentyxsecukinumab | Secukinumab 25 mg/mL | Injection, Solution, ConcentrateIntravenous | 0078-1168 | 00078-1168-61 | — |
| Tafinlardabrafenib | Dabrafenib mesylate 10 mg/1 | Tablet, For suspensionOral | 0078-1154 | 00078-1154-21 | — |
| Mekinisttrametinib | Trametinib dimethyl sulfoxide .05 mg/mL | Powder, For solutionOral | 0078-1161 | 00078-1161-47 | — |
| Vijoicealpelisib | Alpelisib 50 mg/1 | TabletOral | 0078-1021 | 00078-1021-8400078-1021-91 | — |
| Vijoicealpelisib | Alpelisib 125 mg/1 | TabletOral | 0078-1028 | 00078-1028-8400078-1028-91 | — |
| Vijoicealpelisib | — | Kit | 0078-1035 | 00078-1035-0200078-1035-92 | — |
| Pluvictolutetium lu 177 vipivotide tetraxetan | Lutetium lu-177 vipivotide tetraxetan 27 mCi/mL | Injection, SolutionIntravenous | 0078-1217 | 00078-1217-61 | — |
| Locametzkit for the preparation of gallium ga 68 gozetotide | Gozetotide 25 ug/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0078-1224 | 00078-1224-61 | — |
| Leqvioinclisiran | Inclisiran sodium 284 mg/1.5mL | Injection, SolutionSubcutaneous | 0078-1000 | 00078-1000-6000078-1000-98 | — |
| Scemblixasciminib | Asciminib hydrochloride 40 mg/1 | Tablet, Film coatedOral | 0078-1098 | 00078-1098-2000078-1098-94 | — |
| Scemblixasciminib | Asciminib hydrochloride 20 mg/1 | Tablet, Film coatedOral | 0078-1091 | 00078-1091-2000078-1091-94 | — |
| Scemblixasciminib | Asciminib hydrochloride 100 mg/1 | Tablet, Film coatedOral | 0078-1196 | 00078-1196-20 | — |
| Tabrectacapmatinib | Capmatinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | 0078-0709 | 00078-0709-5600078-0709-94 | — |
| Tabrectacapmatinib | Capmatinib hydrochloride 200 mg/1 | Tablet, Film coatedOral | 0078-0716 | 00078-0716-5600078-0716-94 | — |
| Adakveocrizanlizumab | Crizanlizumab 10 mg/mL | InjectionIntravenous | 0078-0883 | 00078-0883-61 | — |
| Beovubrolucizumab | Brolucizumab 6 mg/.05mL | Injection, SolutionIntravitreal | 0078-0827 | 00078-0827-6000078-0827-98 | — |
| Piqrayalpelisib | Alpelisib 200 mg/1 | TabletOral | 0078-0701 | 00078-0701-84 | — |
| Piqrayalpelisib | Alpelisib 150 mg/1 | TabletOral | 0078-0708 | 00078-0708-0200078-0708-91 | — |
| Piqrayalpelisib | — | Kit | 0078-0715 | 00078-0715-0200078-0715-91 | — |
| Mayzentsiponimod | Siponimod .25 mg/1 | Tablet, Film coatedOral | 0078-0979 | 00078-0979-1200078-0979-5000078-0979-89+1 more | — |
| Mayzentsiponimod | Siponimod 2 mg/1 | Tablet, Film coatedOral | 0078-0986 | 00078-0986-1500078-0986-4500078-0986-93+1 more | — |
| Mayzentsiponimod | Siponimod 1 mg/1 | Tablet, Film coatedOral | 0078-1014 | 00078-1014-1500078-1014-93 | — |
| Zykadiaceritinib | Ceritinib 150 mg/1 | Tablet, Film coatedOral | 0078-0694 | 00078-0694-4800078-0694-84 | — |
| Egatentriclabendazole | Triclabendazole 250 mg/1 | TabletOral | 0078-0937 | 00078-0937-91 | — |
| Promactaeltrombopag olamine | Eltrombopag olamine 25 mg/1 | Powder, For suspensionOral | 0078-0697 | 00078-0697-61 | — |
| Promactaeltrombopag olamine | Eltrombopag olamine 12.5 mg/1 | Powder, For suspensionOral | 0078-0972 | 00078-0972-61 | — |
| Kymriahtisagenlecleucel | Tisagenlecleucel 60000000 1/1 | Injection, SuspensionIntravenous | 0078-0958 | 00078-0958-19 | — |
| Kymriahtisagenlecleucel | Tisagenlecleucel 2000000 1/1 | Injection, SuspensionIntravenous | 0078-0846 | 00078-0846-19 | — |
| Jadenudeferasirox | Deferasirox 180 mg/1 | GranuleOral | 0078-0713 | 00078-0713-15 | — |
| Jadenudeferasirox | Deferasirox 360 mg/1 | GranuleOral | 0078-0720 | 00078-0720-15 | — |
| Jadenudeferasirox | Deferasirox 90 mg/1 | GranuleOral | 0078-0727 | 00078-0727-15 | — |
| Rydapt | Midostaurin 25 mg/1 | Capsule, Liquid filledOral | 0078-0698 | 00078-0698-1900078-0698-99 | — |
| Kisqaliribociclib | Ribociclib succinate 200 mg/1 | Tablet, Film coatedOral | 0078-0860 | 00078-0860-01 | — |
| Kisqaliribociclib | Ribociclib succinate 200 mg/1 | Tablet, Film coatedOral | 0078-0867 | 00078-0867-42 | — |
| Kisqaliribociclib | Ribociclib succinate 200 mg/1 | Tablet, Film coatedOral | 0078-0874 | 00078-0874-63 | — |
| Ilariscanakinumab | Canakinumab 150 mg/mL | Injection, SolutionSubcutaneous | 0078-0734 | 00078-0734-61 | — |
| Hycamtintopotecan hydrochloride | Topotecan hydrochloride 4 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0078-0674 | 00078-0674-61 | — |
| Arranonnelarabine | Nelarabine 5 mg/mL | InjectionIntravenous | 0078-0683 | 00078-0683-61 | — |
| Promactaeltrombopag olamine | Eltrombopag olamine 12.5 mg/1 | Tablet, Film coatedOral | 0078-0684 | 00078-0684-15 | — |
| Tykerblapatinib | Lapatinib ditosylate 250 mg/1 | TabletOral | 0078-0671 | 00078-0671-19 | — |
| Sandostatin LAR Depotoctreotide acetate | — | Kit | 0078-0811 | 00078-0811-81 | — |
| Sandostatin LAR Depotoctreotide acetate | — | Kit | 0078-0818 | 00078-0818-81 | — |
| Sandostatin LAR Depotoctreotide acetate | — | Kit | 0078-0825 | 00078-0825-81 | — |
Novartis Pharmaceuticals Corporation: common questions
- What is Novartis Pharmaceuticals Corporation's NDC labeler code?
- 0078. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Novartis Pharmaceuticals Corporation?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.